The World Health Organization commended the Maldives Food and Drug Authority for identifying diethylene glycol and ethylene glycol contaminants in syrups made by PHARMIX Laboratories using a novel screening method. Following alerts from the Maldives, Pakistan's Drug Regulatory Authority halted the company's oral liquid medicine production and issued a recall for five syrup medicines.
One outlet so far Only Maldives Republic has reported this among the sources we monitor. A gap in what we monitor, not proof that others did not report it.
On 16 November 2023, DRAP issued a recall alert for five syrup medicines that PHARMIX Laboratories manufactured.
Word for word from the report in Maldives Republic. Open the report
a paradigm for global health protection
The commendable work of the Maldives Food and Drug Authority, in partnership with WHO, serves as a beacon of success in addressing global health challenges. It underscores the importance of swift action, collaboration, and stringent regula…
Nothing to compare yet. If another monitored source reports it, its headline appears beside this one.
the Drug Regulatory Authority of Pakistan (DRAP) instructed PHARMIX Laboratories to cease the production of all oral liquid dosage medicines.
Word for word from the report in Maldives Republic. Open the report